跳至主要内容
临床试验/NCT02522039
NCT02522039已完成不适用

Effect of Topical Anti-glaucoma Medications on Late Pupillary Light Reflex, as Evaluated by Pupillometry

Glostrup University Hospital, Copenhagen1 个研究点 分布在 1 个国家目标入组 21 人开始时间: 2014年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
21
试验地点
1
主要终点
pupillary constriction measured as the post-illimination pupillay response (PIPR)

研究概览

简要总结

Investigation of the effect on the pupillary constriction by latanoprost, dorzolamide,timolol in healthy subjects. The pupillary constriction is compared to no drug.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Basic Science
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • healthy subjects

排除标准

  • ophthalmological diseases
  • systemic disease
  • refractive error >= 6 diopters

研究组 & 干预措施

Latanoprost

Experimental

solution, 1 drop of 50ug/ml latanoprost, was given to study eye after washout period of 1 week between drugs

干预措施: Latanoprost (Drug)

Timolol

Experimental

solution, 1 drop of 5mg/ml timolol , was given to study eye after washout period of 1 week between drugs

干预措施: Timolol (Drug)

dorzolamide

Experimental

solution, 1 drop of 20 mg/ml dorzolamide, was given to study eye after washout period of 1 week between drugs

干预措施: Dorzolamide (Drug)

结局指标

主要结局

pupillary constriction measured as the post-illimination pupillay response (PIPR)

时间窗: 1 day

The pupillary diameter 0 to 10 seconds after light stimulation, the diameter is measured relative to the initial dark adapted pupil diameter

次要结局

未报告次要终点

研究者

发起方
Glostrup University Hospital, Copenhagen
申办方类型
Other
责任方
Principal Investigator
主要研究者

Birgit Sander

md

Glostrup University Hospital, Copenhagen

研究点 (1)

Loading locations...

相似试验